Back to News
Market Impact: 0.12
SkinHealth Unveils HydraScalp, Hydrafacial Data; Shows Skin And Scalp Benefits
Source: Nasdaq
Healthcare & BiotechProduct Launches
SkinHealth Systems said clinical findings evaluating its HydraScalp with Keravive and Hydrafacial treatments will be presented at the 2026 Science of Skin Summit in Austin, Texas. The announcement highlights ongoing clinical validation of the company’s medical-aesthetics products but provides no efficacy data, financial impact, or updated outlook.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
SKIN0.35
More News
- Wells Fargo sees improvement in a key metric — plus, Lilly gets praise beyond GLP-1s
- Beta Bionics prices $150M public offering at $17.25/share
- Inside South Korea’s university programs offering a direct route to Samsung and SK Hynix
- SpaceX will try to put Starship in orbit for the first time on September 22
- A sharp stock market decline could lie around the corner, Wells Fargo warns
- SpaceX’s Starship is finally set for orbit. A lot is riding on its success.